J. B. Chemicals & Pharmaceuticals Limited (NSE: JBCHEPHARM)

India flag India · Delayed Price · Currency is INR
1,857.05
-2.65 (-0.14%)
Dec 24, 2024, 3:30 PM IST
14.71%
Market Cap 290.21B
Revenue (ttm) 37.11B
Net Income (ttm) 6.11B
Shares Out n/a
EPS (ttm) 38.43
PE Ratio 47.49
Forward PE n/a
Dividend 12.25 (0.66%)
Ex-Dividend Date Aug 14, 2024
Volume 98,743
Open 1,867.05
Previous Close 1,859.70
Day's Range 1,819.40 - 1,878.30
52-Week Range 1,480.00 - 2,030.00
Beta -0.04
Analysts n/a
Price Target n/a
Earnings Date Feb 6, 2025

About NSE: JBCHEPHARM

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company’s API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dosage forms, such as tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, cold rubs, eye drops, troches, and capsules; and soft-cen... [Read more]

Sector Healthcare
Founded 1976
Employees 5,311
Stock Exchange National Stock Exchange of India
Ticker Symbol JBCHEPHARM
Full Company Profile

Financial Performance

In 2023, JBCHEPHARM's revenue was 34.84 billion, an increase of 10.63% compared to the previous year's 31.49 billion. Earnings were 5.53 billion, an increase of 34.84%.

Financial Statements

News

KKR Is Said to Consider Selling $750 Million Stake in JB Pharma

KKR & Co. is considering selling some of its controlling stake in JB Chemicals & Pharmaceuticals Ltd. via a block trade in the market, according to people familiar with the matter.

6 weeks ago - BNN Bloomberg

Stocks to Buy This Diwali: Kotak Securities sees JB Chemicals & Pharma reaching ₹2,255, with a 19.2% upside

Kotak Securities has added JB Chemicals & Pharma to its Diwali 2024 stock picks, assigning it a “Buy” rating with a target price of ₹2,255. Currently trading at ₹1,891, JB Chemicals offers an upside p...

2 months ago - Business Upturn

Pharma Stocks Update: Natco Pharma gains 2.99%, Glenmark rises 0.07%, Granules falls 3.83%

As of 2:38 PM, the Nifty Pharma index saw a mixed performance with some stocks showing notable gains while others faced losses. Natco Pharma, Glenmark, and Ajanta Pharma were the top gainers, while Gr...

2 months ago - Business Upturn

Pharma Stocks Update: Granules up 3.56%, Ajanta Pharma gains 2.24% while JB Chemicals drops 2.82%, Mankind Pharma down 1.40% in mixed pharma stock performance

Pharma stocks have shown mixed performance in today’s trading session, with some major players gaining ground while others face declines. As of now, here’s how key pharmaceutical stocks are performing...

2 months ago - Business Upturn

JB Chemicals faces valuation dispute over KKR’s 54% equity stake, potential M&A deal withdrawal looms; stock falls 4.28%

The largest M&A deal in India’s pharmaceutical industry for 2024 is reportedly facing significant hurdles. According to ET Now, JB Chemicals is in a disagreement over the valuation of KKR’s 54% equity...

3 months ago - Business Upturn